Suramin ameliorates collagen induced arthritis

International Immunopharmacology

Volumn 12, Issue 1, 2012, Pages 288-293

  Sahu, Debasis ^a,b   Saroha, Ashish ^a,c   Roy, Saugata ^a   Das, Sandip ^d   Srivastava, Prem S ^b   Das, Hasi R ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b HAMDARD UNIVERSITY   (India)

^c MAULANA ABUL KALAM AZAD UNIVERSITY OF TECHNOLOGY   (India)

^d UNIVERSITY OF DELHI   (India)

Author keywords

Anti inflammatory; Collagen induced arthritis; Glycoprotein; Pro inflammatory cytokine; Suramin

Indexed keywords

ACUTE PHASE PROTEIN; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; SURAMIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; COLLAGEN INDUCED ARTHRITIS; CONTROLLED STUDY; FEMALE; INFLAMMATION; JOINT DESTRUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SPLEEN; SYNOVIUM;

ACUTE-PHASE PROTEINS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CYTOKINES; FEMALE; JOINTS; RATS; RATS, WISTAR; SURAMIN;

EID: 84856100305     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.12.003     Document Type: Article

References (45)

1. F.W. Jennings, J. Rodgers, B. Bradley, G. Gettinby, P.G. Kennedy, and M. Murray Human African trypanosomiasis: potential therapeutic benefits of an alternative suramin and melarsoprol regimen Parasitol Int 51 4 2002 381 388 (Pubitemid 35287509)
2. H. Schulz-Key, M. Karam, and A. Prost Suramin in the treatment of onchocerciasis: the efficacy of low doses on the parasite in an area with vector control Trop Med Parasitol 36 4 1985 244 248 (Pubitemid 16177100)
3. S. +Takano, S. Gately, M.E. Neville, W.F. Herblin, J.L. Gross, and H. Engelhard Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator Cancer Res 54 10 1994 2654 2660 (Pubitemid 24173754)
4. L. Grazioli, R. Alzani, M. Ciomei, M. Mariani, A. Restivo, and E. Cozzi Inhibitory effect of suramin on receptor binding and cytotoxic activity of tumor necrosis factor alpha Int J Immunopharmacol 14 4 1992 637 642
5. R. Alzani, A. Corti, L. Grazioli, E. Cozzi, P. Ghezzi, and F. Marcucci Suramin induces deoligomerization of human tumor necrosis factor alpha J Biol Chem 268 17 1993 12526 12529 (Pubitemid 23182411)
6. C. Agrawal, S.K. Raghav, B. Gupta, R.H. Das, V.P. Chaturvedi, and K. Goswami Tumor necrosis factor-alpha microsatellite polymorphism association with rheumatoid arthritis in Indian patients Arch Med Res 36 5 2005 555 559 (Pubitemid 41140065)
7. P.T. Nash, and T.H. Florin Tumour necrosis factor inhibitors Med J Aust 183 4 2005 205 208 (Pubitemid 41150331)
8. S.K. Raghav, B. Gupta, C. Agrawal, V.P. Chaturvedi, and H.R. Das Expression of -alpha and related signaling molecules in the peripheral blood mononuclear cells of rheumatoid arthritis patients Mediators Inflamm 2006 3 2006 12682
9. M.M. Rahman, A.R. Lucas, and G. McFadden Viral inhibitors as potential therapeutics Adv Exp Med Biol 666 2009 64 77
10. K.J. Tracey, and A. Cerami Tumor necrosis factor: a pleiotropic cytokine and therapeutic target Annu Rev Med 45 1994 491 503
11. T. Alonzi, E. Fattori, D. Lazzaro, P. Costa, L. Probert, and G. Kollias Interleukin 6 is required for the development of collagen-induced arthritis J Exp Med 187 4 1998 461 468 (Pubitemid 28093348)
12. S.K. Seo, J.H. Choi, Y.H. Kim, W.J. Kang, H.Y. Park, and J.H. Suh 4-1BB-mediated immunotherapy of rheumatoid arthritis Nat Med 10 10 2004 1088 1094 (Pubitemid 39424870)
13. M. Feldmann, F.M. Brennan, and R.N. Maini Role of cytokines in rheumatoid arthritis Annu Rev Immunol 14 1996 397 440 (Pubitemid 26130190)
14. S. Bernatsky, M. Hudson, and S. Suissa Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis Rheumatology (Oxford) 46 7 2007 1157 1160 (Pubitemid 47050621)
15. R. Alzani, E. Cozzi, A. Corti, M. Temponi, D. Trizio, and M. Gigli Mechanism of suramin-induced deoligomerization of tumor necrosis factor alpha Biochemistry 34 19 1995 6344 6350
16. F. Mancini, C.M. Toro, M. Mabilia, M. Giannangeli, M. Pinza, and C. Milanese Inhibition of tumor necrosis factor-alpha (-alpha)/-alpha receptor binding by structural analogues of suramin Biochem Pharmacol 58 5 1999 851 859 (Pubitemid 29329536)
17. G. Strassmann, M. Fong, C.E. Freter, S. Windsor, F. D'Alessandro, and R.P. Nordan Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo J Clin Invest 92 5 1993 2152 2159 (Pubitemid 23333518)
18. T. Shiono, M. Kodama, H. Hanawa, K. Fuse, T. Yamamoto, and Y. Aizawa Suppression of myocardial inflammation using suramin, a growth factor blocker Circ J 66 4 2002 385 389
19. F.H. Durie, R.A. Fava, and R.J. Noelle Collagen-induced arthritis as a model of rheumatoid arthritis Clin Immunol Immunopathol 73 1 1994 11 18 (Pubitemid 24310774)
20. E.F. Rosloniec, M. Cremer, A.H. Kang, L.K. Myers, and D.D. Brand Collagen-induced arthritis Curr Protoc Immunol 2010 Chapter 15:Unit-25
21. S. Biswas, D. Sahu, A. Saroha, and H.R. Das Glycoproteomic analysis of collagen induced arthritis in rats Trends Carbohydr Res 1 2009 12 20
22. K. Arii, Y. Kumon, K. Sugahara, K. Nakatani, Y. Ikeda, and T. Suehiro Edaravone inhibits collagen-induced arthritis possibly through suppression of nuclear factor-kappa B Mol Immunol 45 2 2008 463 469 (Pubitemid 47332633)
23. M.G. Coelho, P.A. Reis, V.B. Gava, P.R. Marques, C.R. Gayer, and G.A. Laranja Anti-arthritic effect and subacute toxicological evaluation of Baccharis genistelloides aqueous extract Toxicol Lett 154 1-2 2004 69 80 (Pubitemid 39314590)
24. H.S. Lin, C.Y. Hu, H.Y. Chan, Y.Y. Liew, H.P. Huang, and L. Lepescheux Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents Br J Pharmacol 150 7 2007 862 872 (Pubitemid 46536628)
25. S.K. Raghav, B. Gupta, A. Shrivastava, and H.R. Das Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1β through suppression of NF-kappaB activation by 3-(1′-1′-dimethyl-allyl)-6- hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L Eur J Pharmacol 560 1 2007 69 80
26. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
27. A. Saroha, S. Biswas, B.P. Chatterjee, and H.R. Das Altered glycosylation and expression of plasma alpha-1-acid glycoprotein and haptoglobin in rheumatoid arthritis J Chromatogr B Analyt Technol Biomed Life Sci 879 20 2011 1839 1843
28. S.K. Raghav, B. Gupta, C. Agrawal, K. Goswami, and H.R. Das Anti-inflammatory effect of Ruta graveolens L. in murine macrophage cells J Ethnopharmacol 104 1-2 2006 234 239 (Pubitemid 43234109)
29. J. Hassan, A. Whelan, B. Bresnihan, and C. Feighery Induction of IgM and IgM-rheumatoid factor synthesis in vitro by indomethacin Rheumatol Int 10 6 1991 235 239
30. T. Sengodan, S. Biradar, V. Rathi, and J.C. Rathi Formulation and evaluation of maltodextrin based proniosomes loaded with indomethacin Int J PharmTechnol Res 1 3 2009 517 523
31. K. Nishiya, N. Hisakawa, T. Hosokawa, K. Hashimoto, and T. Doi Enlarged spleen detected by abdominal ultrasonography in patients with RA Ann Rheum Dis 59 9 2000 751 752
32. G. Bkaily, and P. Orleans-Juste Cytokine-induced free radicals and their roles in myocardial dysfunctions Cardiovasc Res 42 1999 576 577 (Pubitemid 29298124)
33. J.M. Hendriks, G. Hubens, F.L. Wuyts, P. Vermeulen, A. Hubens, and E. Eyskens Experimental study of intraperitoneal suramin on the healing of colonic anastomoses Br J Surg 86 9 1999 1171 1175 (Pubitemid 29427834)
34. A. Ogden, M.G. Wientjes, and J.L. Au Suramin as a chemosensitizer: oral pharmacokinetics in rats Pharm Res 21 11 2004 2058 2063 (Pubitemid 40941226)
35. W.J. Gradishar, G. Soff, J. Liu, A. Cisneros, S. French, and A. Rademaker A pilot trial of suramin in metastatic breast cancer to assess antiangiogenic activity in individual patients Oncology 58 4 2000 324 333 (Pubitemid 30265343)
36. J.J. Knox, and M.J. Moore Treatment of hormone refractory prostate cancer Semin Urol Oncol 19 3 2001 202 211 (Pubitemid 32816500)
37. E.J. Small, M. Meyer, M.E. Marshall, L.M. Reyno, F.J. Meyers, and R.B. Natale Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone J Clin Oncol 18 7 2000 1440 1450 (Pubitemid 30205389)
38. S. Song, B. Yu, Y. Wei, M.G. Wientjes, and J.L. Au Low-dose suramin enhanced paclitaxel activity in chemotherapy-naive and paclitaxel-pretreated human breast xenograft tumors Clin Cancer Res 10 18 Pt 1 2004 6058 6065 (Pubitemid 39287510)
39. R.P. McGeary, A.J. Bennett, Q.B. Tran, K.L. Cosgrove, and B.P. Ross Suramin: clinical uses and structure-activity relationships Mini Rev Med Chem 8 13 2008 1384 1394
40. M. Brigotti, R.R. Alfieri, P.G. Petronini, and D. Carnicelli Inhibition by suramin of protein synthesis in vitro. Ribosomes as the target of the drug Biochimie 88 5 2006 497 503
41. S.K. Raghav, B. Gupta, C. Agrawal, A. Saroha, R.H. Das, and V.P. Chaturvedi Altered expression and glycosylation of plasma proteins in rheumatoid arthritis Glycoconj J 23 3-4 2006 167 173 (Pubitemid 43725196)
42. A. Saroha, and H.R. Das Altered glycosylation in autoimmune diseases Trends Carbohydr Res 3 2011 1 12
43. M.M. Newkirk, P. Apostolakos, C. Neville, and P.R. Fortin Systemic lupus erythematosus, a disease associated with low levels of clusterin/apoJ, an antiinflammatory protein J Rheumatol 26 3 1999 597 603 (Pubitemid 29125578)
44. X. Liang, T. Lin, G. Sun, L. Beasley-Topliffe, J.M. Cavaillon, and H.S. Warren Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages J Leukoc Biol 86 2 2009 229 235
45. I. Isordia-Salas, I.M. Sainz, R.A. Pixley, C. Martinez-Murillo, and R.W. Colman High molecular weight kininogen in inflammation and angiogenesis: a review of its properties and therapeutic applications Rev Invest Clin 57 6 2005 802 813